Week 10: Hypertension Flashcards

1
Q

How is blood pressure regulated in the short-term?

A

The short-term regulation of blood pressure is managed by the Central Nervous System (CNS). The cardiovascular vasomotor control center is in the medulla and pons areas of the brainstem, with additional areas in the hypothalamus, cerebral cortex, and thalamus. The hypothalamic centers regulate cardiovascular responses to changes in temperature, and the cerebral cortex centers adjust cardiac reaction to a variety of emotional states, lastly the brainstem control center regulates heart rate and blood pressure.

The nerve fibers from the cardiovascular control center synapse with automatic neurons that influence the rate of firing of the SA node. An increased heart rate occurs with sympathetic (adrenergic) stimulation. When the parasympathetic nerves to the heart are stimulated (primarily via the vagus nerve), the heart rate slows and the sympathetic nerves to the heart, arterioles, and veins are inhibited. At rest, the heart rate in healthy individuals is primarily under the control of parasympathetic stimulation.

Messages are sent to the brain via the neural reflexes which include a collection of nerves located in the aortic arch, carotid sinuses, and other parts of the heart - these include receptors in the heart such as the baroreceptors and chemoreceptors. The brain receives theses messages and transmits commands to the circulatory system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is blood pressure regulated in the long-term?

A

See slide 22. The renin-angiotensin-aldosterone system is a key homeostatic mechanism that controls blood pressure and fluid balance. Renin is an enzyme secreted by specialized cells in the kidney when blood pressure falls or where there is a decrease in sodium flowing through the kidney tubules. Once in the blood, renin converts the inactive liver protein angiotensinogen to angiotensin I. When passing through the lungs, angiotensin I is converted to angiotensin II, one of the most potent natural vasoconstrictors known. The enzyme responsible for the final step in this system is angiotensin converting enzyme (ACE). The intense vasoconstriction of arterioles caused by angiotensin II raises blood pressure by increasing peripheral resistance. Angiotensin II also stimulates the secretion of two hormones that markedly affect blood pressure: aldosterone and ADH. Aldosterone, a hormone from the adrenal cortex, increases sodium reabsorption in the kidney. The enhanced sodium reabsorption helps the body to retain water, thus increasing blood volume and raising blood pressure. ADH, a hormone from the posterior pituitary, enhances the conservation of water by the kidneys. This raises blood pressure by increasing blood volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Primary Hypertension?

A

Primary hypertension is the result of a complicated interaction of genetics and the environment mediated by a host of neurohumoral effects that influence intravascular volume and PVR. Genetic predisposition to hypertension is thought to be polygenic and associated with epigenetic changes influenced by diet and lifestyle. Genetic risks include defects in renal sodium excretion, insulin sensitivity, activity of the sympathetic nervous system (SNS) and the renin-angiotensin-aldosterone system (RAAS), and cell membrane sodium or calcium transport

There is no exact known cause, but primary hypertension is responsible for 95% of all cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Complicated Hypertension?

A

As hypertension becomes more severe and chronic, tissue damage can occur in the blood vessels and tissues leading to target organ damage in the heart, kidney, brain, and eyes. Cardiovascular complications of sustained hypertension include left ventricular hypertrophy, angina pectoris, heart failure, coronary artery disease, myocardial infarction, and sudden death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Secondary Hypertension?

A

Secondary hypertension is caused by an underlying disease process or medication that raises PVR or cardiac output. This form of hypertension accounts for only 5% to 10% of cases. Examples include renal vascular or parenchymal disease, adrenocortical tumors, adrenomedullary tumors (pheochromocytoma), and drugs (oral contraceptives, corticosteroids, antihistamines). If the cause is identified and removed before permanent structural changes occur, blood pressure returns to normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Malignant Hypertension?

A

Also known as a Hypertensive Crisis, (malignant hypertension) is rapidly progressive hypertension in which systolic pressure is ≥180mm Hg and/or diastolic pressure is ≥120mm Hg and is associated with advanced bilateral retinopathy, encephalopathy, or microangiopathy. It can occur in those with primary hypertension, but the reason some people develop this complication and others do not is unknown. Other causes include complications of pregnancy, cocaine or amphetamine use, reaction to certain medications, adrenal tumors, and alcohol withdrawal. High arterial pressure renders the cerebral arterioles incapable of regulating blood flow to the cerebral capillary beds. High hydrostatic pressures in the capillaries cause vascular fluid to exude into the interstitial space. Retina exhibit hemorrhages, cotton wool spots, and papilledema. If blood pressure is not reduced, cerebral edema and cerebral dysfunction (encephalopathy) increase until death occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Identify the modifiable and non-modifiable risk factors in the development of hypertension

A

Modifiable Risk Factors:
- Socioeconomic status
- Sleep apnea
- Psychosocial stressors
- Increased sodium intake
- Glucose intolerance/Insulin Resistance
- Heavy Alcohol use
- Obesity (increases water retention & inflammation)
- Cigarettes & vapes
- Decreased potassium, magnesium, and calcium

Non-Modifiable Risk Factors:
- Family history (some evidence of genetic influence)
- Race (more prevalent in South Asian & Black communities)
- Gender (females >70, Male >55)
- Advancing age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the pathophysiology of hypertension

A

See slide 20. Multiple mechanisms contribute to the pathophysiology of hypertension; genetic and environmental risks lead to changes in neurohormones and dysfunction of the SNS and RAAS, insulin resistance and obesity, and inflammation.

Obesity contributes to hypertension through changes in adipokines and increased inflammation. The combination of obesity, insulin resistance, SNS and RAAS dysfunction, and inflammation cause sodium and water retention and peripheral vasoconstriction leading to sustained hypertension and organ damage.

Increased vascular volume is related to a decrease in renal excretion of salt, often referred to as a pressure shift in the pressure-natriuresis relationship. Increased SNS activity causes accelerated heart rate and systemic vasoconstriction - these changes increase both cardiac output and peripheral vascular resistance, thus raising blood pressure.

Sustained hypertension results in structural changes in the blood vessels (vascular remodeling) that contributes to hyaline sclerosis and atherosclerosis which can cause retinal changes, renal disease (nephrosclerosis), cardiac disease (coronary artery disease, congestive heart failure), and neurologic disease (stroke, dementia, encephalopathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss dietary requirements for hypertension and the non-pharmacological treatment of clients with hypertension including nutritional modifications

A
  1. Healthy diet in accordance with the DASH (Dietary Approaches to Stop Hypertension) diet: high in fresh fruits and vegetables and low-fat dairy products; low in saturated fat and salt
  2. Regular physical activity: 30 to 60 minutes of moderate cardiorespiratory activity (such as walking, jogging, cycling, or swimming) four to seven times per week
  3. Limited alcohol intake: no more than 2 standard drinks per day (less than 14 per week for men and less than 9 per week for women)
  4. Healthy weight: maintain an ideal body weight (body mass index [BMI] of 18.5 to 24.9 kg/m2; waist circumference <102 cm for men and <88 cm for women)
  5. Restricted salt intake: less than 100 mg/day for individuals who are considered salt-sensitive (such as those over age 45 years, of African descent, or with impaired renal function or diabetes)
  6. Smoke-free environment
  7. Stress management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Hypertension?

A

Hypertension is consistent elevation of systemic arterial blood pressure. It results from a sustained increase in peripheral vascular resistance (PVR), an increase in circulating blood volume and cardiac output, or both. Hypertension is defined as a SUSTAINED systolic blood pressure (SBP) of 140mm Hg or a diastolic blood pressure (DBP) of 90mm Hg or greater after multiple measurements made over several visits.

A client with a SUSTAINED BP on 120-139/80-89 mm Hg is said to be pre-hypertensive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is blood pressure and how is it measured?

A

Blood pressure is the pressure of circulating blood against the walls of blood vessels. Most of this pressure results from the heart pumping blood through the circulatory system. When used without qualification, the term “blood pressure” refers to the pressure in a brachial artery, where it is most commonly measured.

Blood pressure is measured using the systolic and diastolic pressures. The systolic pressure is the pressure exerted when the ventricles contract and blood is pumped out into the circulation. Diastolic pressure is measured when the ventricles relax and fill with blood.

Blood pressure is impacted by cardiac output (i.e., increased stroke volume or heart rate), peripheral resistance (i.e., sympathetic nervous system activity, renin/angiotensin II, increase in blood viscosity), and blood volume (i.e., fluid loss/dehydration, fluid retention from increased aldosterone or increased anti-diuretic hormone) - increases in these factors will increase BP.

Blood pressure = Cardiac output x Peripheral Resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Pulse Pressure?

A

The pulse pressure is the difference between the systolic pressure and the diastolic pressure (Ps - Pd) and is typically between 40-50 mm Hg. It is directly related to arterial wall stiffness and stroke volume. A large pulse pressure tells us that possibly the vessels are very rigid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Mean Arterial Pressure (MAP)?

A

MAP is the average pressure in the arteries throughout the cardiac cycle, it depends on the elastic properties of the arterial walls and the mean volume of blood in the arterial system. MAP can be approximated from the measured values of the systolic and diastolic pressures and is an overall indicator of tissue perfusion. The normal range for MAP is 70 to 110mm Hg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Cardiac Ouput?

A

The cardiac output (minute volume) of the heart can be changed by alterations in the heart rate, stroke volume (volume of blood ejected during each ventricular contraction), or both. An increase in cardiac output without a decrease in peripheral resistance will cause the MAP and flow rate to increase. The higher arterial pressure increases blood flow through the arterioles. On the other hand, a decrease in the cardiac output causes a drop in the MAP and arteriolar flow if peripheral resistance stays constant

Amount of blood pumped by a ventricle in 1 minute and is increased by any condition that increases heart rate or stroke volume.

CO = HR X SV
(heart rate x stroke volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Stroke Volume?

A

The amount of blood pumped by the left ventricle in one contraction. Stroke volume could be impacted by a weak ventricle, a prolapsed valve or an incompetent valve. Stroke volume is controlled by preload, contractility and afterload.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Systemic Vascular Resistance (SVR)?

A

It is the force opposing movement of blood within vessels. To elaborate, Total resistance in the systemic circulation, known as either SVR or TPR, is primarily a function of arteriolar diameter. If cardiac output remains constant, arteriolar constriction raises the MAP by reducing the flow of blood into the capillaries, whereas arteriolar dilation has the opposite effect. Reflex control of total cardiac output and peripheral resistance includes (1) sympathetic stimulation of the heart, arterioles, and veins; and (2) parasympathetic stimulation of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Preload?

A

Preload involves the filling of the ventricles but is actually a measure of stretch in the fibers; how much blood is going in and what is the degree of stretch - through this measurement, we understand the ventricles ability to RECOIL.

Preload is the volume and pressure inside the ventricle at the end of diastole (ventricular end-diastolic volume [VEDV] and pressure [VEDP]). Preload is determined by two primary factors: (1) the amount of blood left in the ventricle after systole (end-systolic volume) and (2) the amount of venous blood returning to the ventricle during diastole. End-systolic volume is dependent on the strength of ventricular contraction and the resistance to ventricular emptying. Venous return is dependent on blood volume and flow through the venous system and the atrioventricular valves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Afterload?

A

Afterload is how hard the ventricle has to work to eject blood, it is a measure of CONTRACTILITY.

Ventricular afterload is the resistance to ejection of blood from the ventricle. It is the load the muscle must move during contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are Baroreceptors?

A

The baroreceptors are located in the aortic arch and carotid arteries, they are a neural reflex involved in the short-term regulation of blood pressure. If blood pressure decreases, the baroreceptor reflex accelerates the heart rate, increases myocardial contractility, and increases vascular smooth muscle contraction in the arterioles, thus raising blood pressure. When blood pressure increases, the baroreceptors increase their rate of discharge, sending neural impulses to increase parasympathetic activity and decrease sympathetic activity - causing the resistance arteries to dilate, decreasing myocardial contractility and the heart rate.

20
Q

What are Chemoreceptors?

A

Chemoreceptors are part of the neural reflex involved in the short-term regulation of blood pressure. They have the ability to sense changes in O2 content, pH, or CO2 levels in the blood and respond accordingly.

21
Q

Describe the role of the sympathetic nervous system in hypertension

A

Sympathetic nervous system activity results in increased heart rate and peripheral resistance, insulin resistance (resulting in endothelial dysfunction), vascular remodeling and procoagulant effects. Vascular remodeling, coagulation, and endothelial dysfunction all increase the narrowing of vessels and vasospasm which can contribute to hypertension.

22
Q

Describe the effect of hormonal regulation in blood pressure

A

Hormones influence blood pressure regulation through their effects on vascular smooth muscle and blood volume. By constricting or dilating the arterioles in organs, hormones can (1) increase or decrease the blood flow in response to the body’s needs, (2) redistribute blood volume during hemorrhage or shock, and (3) regulate heat loss.

The key vasoconstrictor hormones include angiotensin II, antidiuretic hormone (ADH; vasopressin), epinephrine, and norepinephrine.

The main vasodilator hormones are the atrial natriuretic hormones, nitric oxide, adrenomedullin, and endothelins.

23
Q

Discuss the role of vasodilator hormones in blood pressure regulation

A

There are numerous vasodilator hormones, most of which have other important effects on blood volume and vascular function. The natriuretic peptides include atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), C-type natriuretic peptide (CNP), and urodilatin. These hormones function both as vasodilators and regulators of sodium and water excretion (natriuresis and diuresis). Increased pressure or diastolic volume in the heart stimulates the release of these peptide hormones which then stimulate secretion of sodium and water from the kidney.

24
Q

Discuss the role of vasoconstrictor hormones in blood pressure regulation

A

The vasoconstrictor hormones include epinephrine, norepinephrine, angiotensin II, which is part of the renin-angiotensin, aldosterone system (RAAS) and ADH.

Epinephrine is released from the adrenal medulla and causes vasoconstriction in most vascular beds except coronary, liver and skeletal muscle circulations.

Norepinephrine is also released from the adrenal medulla. It primarily acts as a neurotransmitter, but it serves as a potent vasoconstrictor - more so than epinephrine!

ADH is a vasoconstricting hormone and affects blood pressure by increasing blood volume by reabsorption of water from the distal tubule and collecting duct of the nephron.

Angiotensin II is a vasoconstricting hormone.

25
Q

How does inflammation contribute to hypertension?

A

Through a decreased production of vasodilators, such as Nitrous Oxide and an increased production of vasoconstrictors, such as endothelin.

26
Q

How does obesity contribute to hypertension?

A

Obesity causes changes in adipokines (e.g., leptins, resistin, and adiponectin) associated with increased SNS and RAAS activity. It is also associated with inflammation, small artery remodeling, endothelial dysfunction, insulin resistance, and an increased risk for cardiovascular complications from HTN.

27
Q

How does insulin resistance contribute to hypertension?

A

Insulin resistance is associated with endothelial injury and affects renal function, causing renal salt and water retention and is also associated with increased SNS activity and RAAS activity.

28
Q

Discuss complications related to hypertension

A

Complications are various but include:
- left ventricular hypertrophy
- myocardial ischemia
- heart failure
- myocardial infarction
- renal disease
- decreased glomerular filtration
- vascular dementia
- aneurysm
- transient ischemic attacks
- hypertensive retinopathy
- retinal exudates
- intermittent claudication
- gangrene

29
Q

Discuss the clinical manifestations and routine tests conducted for hypertension

A

Early stages of hypertension have no clinical manifestations other than elevated BP - it is often called a SILENT DISEASE!

Routine tests include:
- Urinalysis
- Blood chemistry (K, Na, creatinine)
- Fasting blood glucose and/or glycated hemoglobin (A1C)
- Serum total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides
- Lipids may be drawn fasting or non-fasting
- Standard 12-lead electrocardiography

30
Q

How is hypertension diagnosed?

A

Diagnosis involves a measurement of blood pressure on at least 2 separate occasions averaging 2 readings at least 2 minutes apart. With individuals seated, arm supported at heart level, after 5 minutes of rest, with no smoking or caffeine intake in past 30 minutes.

31
Q

If the blood pressure is within normal range (BP <120/80 mm Hg) what is the recommendation for treatment and follow-up?

A

Promote optimal lifestyle habits and re-assess in 1 year

32
Q

If the blood pressure is considered elevated but not hypertensive (BP 120-129/<80 mm Hg) what is the recommendation for treatment and follow-up?

A

Nonpharmacological therapy (e.g., diet and lifestyle changes) and re-assess in 3-6 months

33
Q

If the blood pressure is considered Stage I hypertension (BP 130-139/80-89 mm Hg) what is the recommendation for treatment and follow-up?

A

Is there a clinical ADCVD or estimated 10-y CVD risk >10%? If no, non-pharmacological therapy and re-assess in 3 to 6 months; if yes, non-pharmacological therapy and BP-lowering medication and re-assess in 1 month.

If BP goal is met re-assess in 3-6 months; if not met, assess and optimize adherence to therapy and consider intensification of therapy.

34
Q

If the blood pressure is considered Stage II hypertension (BP >140/90 mm Hg) what is the recommendation for treatment and follow-up?

A

Nonpharmacological therapy and BP lowering medication, re-assess in 1 month.

If BP goal is met re-assess in 3-6 months; if not met, assess and optimize adherence to therapy and consider intensification of therapy.

35
Q

Why is hypertension considered a “Silent Killer”?

A

Because most people who have it don’t have any symptoms. And that silence can be deadly. Left unmanaged, hypertension can result in:
- Retinal changes
- Renal disease
- Cardiac disease
- Coronary artery disease
- Heart failure
- Neurologic disease, including: stroke, dementia, and encephalopathy

36
Q

How is hypertension treated pharmacologically? What are the 4 most common types of anti-hypertensives?

A

Hypertension is most commonly treated with:
1. Diuretics
2. Calcium Channel Blockers
3. Agents affecting the renin-angiotensin-aldosterone system
4. Adrenergic agents

37
Q

How do hypertensive drugs impact cardiac output?

A

The volume of blood pumped per minute is called the cardiac output. The higher the cardiac output, the higher the blood pressure. Cardiac output is determined by heart rate and stroke volume, which is the amount of blood pumped by a ventricle in one contraction. This is important to pharmacology because drugs that change the cardiac output, stroke volume, or heart rate have the potential to influence a client’s blood pressure. Hypertensive drugs may reduce cardiac output through preload, heart rate and/or contractility.

38
Q

How do diuretics reduce hypertension?

A

Diuretics are often the first-line medications for HTN because they have few side effects and can control minor to moderate hypertension. Although many different diuretics are available for hypertension, all produce a similar result: the reduction of blood volume through the urinary excretion of water and electrolytes. Electrolytes are ions such as sodium (Na+), calcium (Ca+2), chloride (Cl−), and potassium (K+). The mechanism by which diuretics reduce blood volume (specifically where and how the kidney is affected) differs among the various classes of diuretic. When a drug changes urine composition or output, electrolyte depletion is possible; the specific electrolyte lost is dependent on the mechanism of action of the particular drug. Potassium loss (hypokalemia) is of particular concern for loop and thiazide diuretics.

39
Q

What acid-based imbalance can occur with non-potassium sparing diuretics? Why?

A

Metabolic alkalosis may occur if potassium is not being spared, resulting in low serum potassium. To correct the deficit, potassium will defuse out of the cells. This will leave the cells electrically negative (K+ leaves), so Hydrogen (H+) will diffuse into the cells to remain electrical neutrality (homeostasis). Because hydrogen has defused into the cells, we now have a low potential for hydrogen and a metabolically alkaline state.

40
Q

Where does Furosemide act in the nephron to eliminate water?

A

Furosemide is a loop diuretic and primarily act in the ascending loop of Henle to inhibit the reabsorption of sodium and chloride. This will result in the excretion of sodium, calcium, magnesium, chlorine, water and some potassium. Potassium will primarily be excreted in the distal tubule of the kidney.

41
Q

Where dose Hydrochlorothiazide act in the nephron to eliminate water?

A

A shorter-acting thiazide diuretic, it acts on the distal tubule in the kidney to increase excretion of sodium, water, chlorine, and potassium.

42
Q

How are calcium channel blockers used in the treatment of hypertension?

A

Contraction of muscle is regulated by the amount of calcium ion inside the cell. When calcium enters the cell through channels in the plasma membrane, muscular contraction is initiated. CCBs block these channels and inhibit calcium from entering the cell, limiting muscular contraction. At low doses, CCBs cause the smooth muscle in arterioles to relax, lowering peripheral resistance and decreasing blood pressure. Some CCBs such as nifedipine (Adalat) are selective for calcium channels in arterioles, while others such as verapamil (Isoptin) affect channels in both arterioles and the myocardium.

We reduce the afterload (the amount of force required to pump blood out), because we have changed the systemic resistance!

43
Q

How do ACE inhibitors and angiotensin II receptor blockers treat hypertension?

A

Drugs blocking the renin-angiotensin-aldosterone system prevent the intense vasoconstriction caused by angiotensin II. These drugs also decrease blood volume, which enhances their antihypertensive effect.

44
Q

Why might a client experience hyperkalemia when taking enalapril?

A

Hyperkalemia may result from the interruption of the RAAS system; sodium and water are not being retained - they are being excreted, which will result in potassium being retained.

45
Q

Angiotensin II receptors blockers (ARBs) are prescribed for client’s who cannot tolerate angiotensin converting enzyme inhibitors (ACEIs), why would a client not be able to tolerate ACEIs?

A

Side effects of ACE inhibitors are usually minor and include persistent cough and postural hypotension, particularly following the first few doses of the drug. The most serious adverse effect is the development of angioedema, an acute hypersensitivity reaction featuring non-inflammatory swelling of the skin, mucous membranes, and other organs. Angioedema may be life-threatening; laryngeal swelling can lead to asphyxia and death. The development of angioedema usually occurs within days of taking an ACE inhibitor; however, it can occur as a delayed reaction months or even years into therapy. If angioedema is suspected, therapy must be discontinued immediately.

46
Q

How are adrenergic agents used to treat blood pressure?

A

Antihypertensive autonomic agents are available to block alpha1, beta1, and/or beta2 receptors, or stimulate alpha2 receptors in the brainstem (centrally acting). These drugs impact the sympathetic nervous system through several distinct mechanisms, all with the effect of lowering BP. These include:
* Blockade of alpha1 receptors in the arterioles
* Selective blockade of beta1 receptors in the heart
* Non-selective blockade of both beta1 and beta2 receptors
* Non-selective blockade of both alpha and beta receptors
* Stimulation of alpha2 receptors in the brainstem (centrally acting)
* Blockade of peripheral adrenergic neurons